Order Entry
Canada
ContactUsLinkComponent
SCREEN-WELL® Neurotransmitter Library (10 Plate Set), Enzo Life Sciences
SCREEN-WELL® Neurotransmitter Library (10 Plate Set), Enzo Life Sciences
Catalog # 89156-266
Supplier:  Enzo Life Sciences
CAS Number:  
SCREEN-WELL® Neurotransmitter Library (10 Plate Set), Enzo Life Sciences
Catalog # 89156-266
Supplier:  Enzo Life Sciences
Supplier Number:  BML-2810-0500
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products, please provide identification that includes your business name and shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of identification are:

  • • Issued document with your organization's Federal Tax ID Number
  • • Government issued document with your organization's Resale Tax ID Number
  • • Any other Government ID that includes the business name and address

Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Source:
  • Species:
  • Size:
    1 Library (500 µl/well)
  • Environmentally Preferable:
  • Cat. no.:
    89156-266
  • Supplier No.:
    2810-0500

Specifications

About this item

The Screen-Well neurotransmitter library contains 681 CNS receptor ligands in a 96-well format.

Includes 13 classes of receptor ligands in 10 deep-well plates (Adrenergis; Histaminergics, Melatonin ligands; Dopaminergics; Ionotropic; Glutamatergics; Serotonergics; Metabotropic; Glutamatergics; Opioids, Sigma ligands; GABAergics; Cholinergics; Purinergics; Adenosines). Each ligand is supplied in solution in a biocompatible solvent at a standard concentration of 10mM (Opioid peptides are supplied at a concentrations of 1mM). Plates are available as a complete set, or individually. Supporting data are included.

Ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, validating new assays, and for routine pharmacological applications.